Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker KURA
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 29, 2026 | Kathleen Ford Chief Operating Officer | KURA Kura Oncology, Inc. | Sale | 3,668 | $10.75 | $39.4K Sale | Form 4 ↗ |
| Sep 29, 2026 | Mollie Leoni Chief Medical Officer | KURA Kura Oncology, Inc. | Sale | 28,802 | $10.75 | $309.6K Sale | Form 4 ↗ |
| Sep 29, 2026 | Brian T. Powl Chief Commercial Officer | KURA Kura Oncology, Inc. | Sale | 15,430 | $10.75 | $165.9K Sale | Form 4 ↗ |
| Sep 28, 2026 | Teresa Brophy Bair Chief Legal Officer | KURA Kura Oncology, Inc. | Sale | 8,442 | $10.50 | $88.6K Sale | Form 4 ↗ |
| Sep 28, 2026 | Kathleen Ford Chief Operating Officer | KURA Kura Oncology, Inc. | Sale | 6,906 | $10.50 | $72.5K Sale | Form 4 ↗ |
| Sep 28, 2026 | Mollie Leoni Chief Medical Officer | KURA Kura Oncology, Inc. | Sale | 12,448 | $10.50 | $130.7K Sale | Form 4 ↗ |
| Sep 28, 2026 | Thomas James Doyle SVP, Finance & Accounting | KURA Kura Oncology, Inc. | Sale | 4,607 | $10.50 | $48.4K Sale | Form 4 ↗ |
| Sep 28, 2026 | Brian T. Powl Chief Commercial Officer | KURA Kura Oncology, Inc. | Sale | 8,000 | $10.56 | $84.5K Sale | Form 4 ↗ |
| Sep 28, 2026 | Brian T. Powl Chief Commercial Officer | KURA Kura Oncology, Inc. | Sale | 9,020 | $10.50 | $94.7K Sale | Form 4 ↗ |
| Sep 24, 2026 | Francis Burrows Chief Scientific Officer | KURA Kura Oncology, Inc. | Sale | 20,726 | $10.83 | $224.5K Sale | Form 4 ↗ |
| Aug 24, 2026 | Troy Edward Wilson President and CEO, Director | KURA Kura Oncology, Inc. | Buy | 100,000 | $12.39 | $1.2M Buy | Form 4 ↗ |
| Aug 21, 2026 | Brian T. Powl Chief Commercial Officer | KURA Kura Oncology, Inc. | Sale | 4,345 | $11.89 | $51.7K Sale | Form 4 ↗ |
| Aug 19, 2026 | Teresa Brophy Bair Chief Legal Officer | KURA Kura Oncology, Inc. | Sale | 31,487 | $12.63 | $397.7K Sale | Form 4 ↗ |
| Aug 17, 2026 | Troy Edward Wilson President and CEO, Director | KURA Kura Oncology, Inc. | Buy | 100,000 | $11.12 | $1.1M Buy | Form 4 ↗ |
| Jun 18, 2026 | Mollie Leoni Chief Medical Officer | KURA Kura Oncology, Inc. | Sale | 84,929 | $9.82 | $834.0K Sale | Form 4 ↗ |
| May 21, 2026 | Brian T. Powl Chief Commercial Officer | KURA Kura Oncology, Inc. | Sale | 10,000 | $11.00 | $110.0K Sale | Form 4 ↗ |
| May 19, 2026 | Kathleen Ford Chief Operating Officer | KURA Kura Oncology, Inc. | Sale | 2,257 | $9.08 | $20.5K Sale | Form 4 ↗ |
| May 19, 2026 | Brian T. Powl Chief Commercial Officer | KURA Kura Oncology, Inc. | Sale | 339 | $9.21 | $3,122 Sale | Form 4 ↗ |
| May 18, 2026 | Teresa Brophy Bair Chief Legal Officer | KURA Kura Oncology, Inc. | Sale | 2,256 | $9.38 | $21.2K Sale | Form 4 ↗ |
| Jan 27, 2026 | Francis Burrows Chief Scientific Officer | KURA Kura Oncology, Inc. | Sale | 1,311 | $8.46 | $11.1K Sale | Form 4 ↗ |
| Jan 27, 2026 | Brian T. Powl Chief Commercial Officer | KURA Kura Oncology, Inc. | Sale | 1,572 | $8.46 | $13.3K Sale | Form 4 ↗ |
| Jan 27, 2026 | Brian T. Powl Chief Commercial Officer | KURA Kura Oncology, Inc. | Sale | 4,842 | $8.46 | $41.0K Sale | Form 4 ↗ |
| Jan 27, 2026 | Kathleen Ford Chief Operating Officer | KURA Kura Oncology, Inc. | Sale | 1,813 | $8.46 | $15.3K Sale | Form 4 ↗ |
| Jan 27, 2026 | Mollie Leoni Chief Medical Officer | KURA Kura Oncology, Inc. | Sale | 1,341 | $8.46 | $11.3K Sale | Form 4 ↗ |
| Jan 27, 2026 | Mollie Leoni Chief Medical Officer | KURA Kura Oncology, Inc. | Sale | 951 | $8.46 | $8,045 Sale | Form 4 ↗ |
| Jan 27, 2026 | Mollie Leoni Chief Medical Officer | KURA Kura Oncology, Inc. | Sale | 2,233 | $8.46 | $18.9K Sale | Form 4 ↗ |
| Jan 27, 2026 | Mollie Leoni Chief Medical Officer | KURA Kura Oncology, Inc. | Sale | 3,655 | $8.46 | $30.9K Sale | Form 4 ↗ |
| Jan 27, 2026 | Thomas James Doyle SVP, Finance & Accounting | KURA Kura Oncology, Inc. | Sale | 881 | $8.46 | $7,453 Sale | Form 4 ↗ |
| Jan 27, 2026 | Thomas James Doyle SVP, Finance & Accounting | KURA Kura Oncology, Inc. | Sale | 2,226 | $8.46 | $18.8K Sale | Form 4 ↗ |
| Jan 27, 2026 | Thomas James Doyle SVP, Finance & Accounting | KURA Kura Oncology, Inc. | Sale | 695 | $8.46 | $5,880 Sale | Form 4 ↗ |
| Jan 27, 2026 | Thomas James Doyle SVP, Finance & Accounting | KURA Kura Oncology, Inc. | Sale | 1,114 | $8.46 | $9,424 Sale | Form 4 ↗ |
| Jan 27, 2026 | Thomas James Doyle SVP, Finance & Accounting | KURA Kura Oncology, Inc. | Sale | 2,226 | $8.46 | $18.8K Sale | Form 4 ↗ |
| Jan 27, 2026 | Teresa Brophy Bair Chief Legal Officer | KURA Kura Oncology, Inc. | Sale | 4,777 | $8.46 | $40.4K Sale | Form 4 ↗ |
| Jan 27, 2026 | Teresa Brophy Bair Chief Legal Officer | KURA Kura Oncology, Inc. | Sale | 2,335 | $8.46 | $19.8K Sale | Form 4 ↗ |
| Jan 27, 2026 | Teresa Brophy Bair Chief Legal Officer | KURA Kura Oncology, Inc. | Sale | 4,096 | $8.46 | $34.7K Sale | Form 4 ↗ |
| Dec 18, 2025 | Francis Burrows Chief Scientific Officer | KURA Kura Oncology, Inc. | Sale | 23,726 | $9.78 | $232.0K Sale | Form 4 ↗ |
| Dec 9, 2025 | Faheem Hasnain Director | KURA Kura Oncology, Inc. | Sale | 10,000 | $10.98 | $109.8K Sale | Form 4 ↗ |
| Nov 14, 2025 | Teresa Brophy Bair Chief Legal Officer | KURA Kura Oncology, Inc. | Sale | 8,804 | $11.18 | $98.4K Sale | Form 4 ↗ |
| Nov 14, 2025 | Brian T. Powl Chief Commercial Officer | KURA Kura Oncology, Inc. | Sale | 8,887 | $11.18 | $99.4K Sale | Form 4 ↗ |
| Nov 14, 2025 | Mollie Leoni Chief Medical Officer | KURA Kura Oncology, Inc. | Sale | 15,485 | $11.18 | $173.1K Sale | Form 4 ↗ |
| Nov 14, 2025 | Thomas James Doyle SVP, Finance & Accounting | KURA Kura Oncology, Inc. | Sale | 4,539 | $11.18 | $50.7K Sale | Form 4 ↗ |
| Nov 14, 2025 | Kathleen Ford Chief Operating Officer | KURA Kura Oncology, Inc. | Sale | 6,902 | $11.18 | $77.2K Sale | Form 4 ↗ |
| Sep 29, 2025 | Brian T. Powl Chief Commercial Officer | KURA Kura Oncology, Inc. | Sale | 8,891 | $8.94 | $79.5K Sale | Form 4 ↗ |
| Sep 29, 2025 | Teresa Brophy Bair Chief Legal Officer | KURA Kura Oncology, Inc. | Sale | 8,805 | $8.94 | $78.7K Sale | Form 4 ↗ |
| Sep 29, 2025 | Kathleen Ford Chief Operating Officer | KURA Kura Oncology, Inc. | Sale | 6,892 | $8.94 | $61.6K Sale | Form 4 ↗ |
| Sep 29, 2025 | Mollie Leoni Chief Medical Officer | KURA Kura Oncology, Inc. | Sale | 12,314 | $8.94 | $110.1K Sale | Form 4 ↗ |
| Sep 29, 2025 | Troy Edward Wilson President and CEO, Director | KURA Kura Oncology, Inc. | Sale | 36,615 | $8.94 | $327.3K Sale | Form 4 ↗ |
| Sep 29, 2025 | Thomas James Doyle SVP, Finance & Accounting | KURA Kura Oncology, Inc. | Sale | 4,541 | $8.94 | $40.6K Sale | Form 4 ↗ |
| Sep 8, 2025 | Troy Edward Wilson President & CEO, Director | KURA Kura Oncology, Inc. | Buy | 50,000 | $8.20 | $410.0K Buy | Form 4 ↗ |
| Aug 13, 2025 | Troy Edward Wilson President and CEO, Director | KURA Kura Oncology, Inc. | Buy | 13,494 | $6.64 | $89.6K Buy | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:12 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances